Nyuma Mbewe

Dr. Nyuma Mbewe

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2022 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
NMNyuma Mbewe
Nyuma Mbewe
MVMichael J. Vinikoor
Michael J. Vinikoor
SFSombo Fwoloshi
Sombo Fwoloshi
MMMundia Mwitumwa
Mundia Mwitumwa
SLShabir Lakhi
Shabir Lakhi
CCCassidy W. Claassen
Cassidy W. Claassen
Background: Zambia recently achieved UNAIDS 90-90-90 treatment targets for HIV epidemic control; however, inpatient facilities continue to face a large burden of patients with advanced HIV disease and HIV-related mortality. Management of advanced HIV disease, following guidelines from outpatient settings, may be more difficult within complex inpatient settings. We evaluated adherence to HIV guidelines during hospitalization, including opportunistic infection (OI) screening, treatment, and prophylaxis. Methods: We reviewed inpatient medical records of people living with HIV (PLHIV) admitted to the University Teaching Hospital in Lusaka, Zambia between December 1, 2018 and April 30, 2019. We collected data on patient demographics, antiretroviral therapy (ART), HIV biomarkers, and OI screening and treatment—including tuberculosis (TB), Cryptococcus, and OI prophylaxis with co-trimoxazole (CTX). Screening and treatment cascades were constructed based on the 2017 WHO Advanced HIV Guidelines. Results: We reviewed files from 200 charts of patients with advanced HIV disease; of these 92% (184/200) had been on ART previously; 58.1% (107/184) for more than 12 months. HIV viral load (VL) testing was uncommon but half of VL results were high. 39% (77/200) of patients had a documented CD4 count result. Of the 172 patients not on anti-TB treatment (ATT) on admission, TB diagnostic tests (either sputum Xpert MTB/RIF MTB/RIF or urine TB-LAM) were requested for 105 (61%) and resulted for 60 of the 105 (57%). Nine of the 14 patients (64%) with a positive lab result for TB died before results were available. Testing for Cryptococcosis was performed predominantly in patients with symptoms of meningitis. Urine TB-LAM testing was rarely performed. Conclusions: At a referral hospital in Zambia, CD4 testing was inconsistent due to laboratory challenges and this reduced recognition of AHD and implementation of AHD guidelines. HIV programs can potentially reduce mortality and identify PLHIV with retention and adherence issues through strengthening inpatient activities, including reflex VL testing, TB-LAM and serum CrAg during hospitalization.

8 May 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
NMNyuma Mbewe
Nyuma Mbewe
TITadatsugu Imamura
Tadatsugu Imamura
SSSuilanji Sivile
Suilanji Sivile
ASAnnel Sinkala
Annel Sinkala
PZPaul Zulu
Paul Zulu
RCRoma Chilengi
Roma Chilengi
Background: Zambia experienced the largest cholera outbreak in the country history in 2023–2024 in the capital, Lusaka. This study aimed to identify the clinical characteristics of the adult patients hospitalized at the community and referral cholera treatment centers (CTCs) to determine factors associated with their severe clinical outcomes during the outbreak. Methods: Clinical information on the adult patients with cholera in the community and referral CTCs was retrospectively analyzed. Clinical factors associated with the fatal outcome were explored by multivariate analysis, using Firth's penalized logistic regression. Results: A total of 6578 adult cases were identified. The overall case fatality rate was 1.0% (51 of 5020), and it was highest in a referral CTC specializing in patients with underlying conditions (4.1% [32 of 772]). In the multivariate analysis, age (odds ratio, 1.05 [95% confidence interval, 1.02–1.09]), human immunodeficiency virus infections (5.68 [2.12–15.30]), diabetes mellitus (8.21 [1.38–34.00]), and severe dehydration at admission (5.97 [1.29–56.94]) were independently correlated with fatal outcomes. Conclusions: Clinical factors, including age, underlying conditions, and disease severity at admission, were shown to be associated with severe clinical outcomes in adult patients with cholera. Enhanced case management strategies targeted for such high-risk groups might be beneficial in reducing the case fatality rate during cholera outbreaks.

23 June 2025 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
NMNyuma Mbewe
Nyuma Mbewe
JTJohn Tembo
John Tembo
MKMpanga Kasonde
Mpanga Kasonde
KMKelvin Mwangilwa
Kelvin Mwangilwa
PZPaul Msanzya Zulu
Paul Msanzya Zulu
MGMartin Peter Grobusch
Martin Peter Grobusch
Background: Cholera outbreaks are increasing in frequency and severity, particularly in Sub-Saharan Africa. Zambia, committed to ending cholera by 2025, instead experienced its most significant outbreak in 2024. This review examines the perceived regression in elimination efforts by addressing two questions: (i) What is known about cholera in Zambia? and (ii) What are the main suggested mechanisms and strategies to further elimination efforts in the region?. Methodology/principal findings: A scoping literature search was conducted in PUBMED to identify relevant qualitative and quantitative research studies published between 1st January 2013 and 30th June 2024 using the search terms ‘cholera’ and ‘Zambia’. We identified 53 relevant publications. With the increasing influence of climate change, population growth, and rural-urban migration, further increases in outbreak frequency and magnitude are expected. Risk factors for recurrent outbreaks, including poor access to water, sanitation, and hygiene (WASH) services in unplanned urban settlements and rural fishing villages, continue to derail elimination efforts. Interventions are best planned at a decentralised, community-centric approach to prevent elimination and reintroduction at the district level. Pre-emptive vaccination campaigns before the rainy season and climate-resilient WASH infrastructure in cholera hotspots are also recommended. Conclusions/significance: The goal to eliminate cholera by 2025 was unrealistic, as evidence points to the disease becoming endemic. Our findings confirm the need to align health and WASH investments with the Global Roadmap to Cholera Elimination by 2030 through a climate-focused lens. Recommendations for cholera elimination, including improved access to safe drinking water and sanitation, remain elusive in many low-income settings like Zambia. Patient-level information on survival and transmissibility is lacking. New research tailored to country-level solutions and enhancing community participation is urgently required. Insights from this review will be integrated into the next iteration of the National Cholera Control Plan and could apply to other countries with similar settings.

11 August 2023 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
FMFrancis Mupeta
Francis Mupeta
SSSuilanji Sivile
Suilanji Sivile
MTMona-Gekanju Toeque
Mona-Gekanju Toeque
SFSombo Fwoloshi
Sombo Fwoloshi
PZPaul Msanzya Zulu
Paul Msanzya Zulu
CCCassidy W. Claassen
Cassidy W. Claassen
The global health exchange program between the University Teaching Hospitals (UTH) of Lusaka, Zambia and the University of Maryland, Baltimore (UMB) has been operating since 2015. As trainees and facilitators of this exchange program, we describe our experiences working in Lusaka and Baltimore, and strengths and challenges of the partnership. Since 2015, we have facilitated rotations for 71 UMB trainees, who spent four weeks on the Infectious Disease (ID) team at UTH. Since 2019 with funding from UMB, nine UTH ID trainee physicians spent up to six weeks each rotating on various ID consult services at University of Maryland Medical Center (UMMC). Challenges in global health rotations can include inadequate preparation or inappropriate expectations among high-income country trainees, low-value experiences for low- and middle-income country trainees, lack of appropriate mentorship at sites, and power imbalances in research collaborations. We try to mitigate these issues by ensuring pre-departure and on-site orientation for UMB trainees, cross-cultural mentored experiences for all trainees, and intentional sharing of authorship and credit on scientific collaborations. We present a description of our medical education collaboration as a successful model for building equitable and reciprocal collaborations between low- and middle-income countries and high-income countries, and offer suggestions for future program initiatives to enhance global health education equity among participants and organizations.

2 December 2025 in Microbial Genomics
Verified
Journal Article
Open access
HNHarriet Ng'OMbe
Harriet Ng'OMbe
CLCharlie C. Luchen
Charlie C. Luchen
LBLia Bote
Lia Bote
MKMpanga Kasonde
Mpanga Kasonde
KMKunda Musonda
Kunda Musonda
NTNicholas R. Thomson
Nicholas R. Thomson
Introduction. Cholera, caused by Vibrio cholerae , remains a priority public health concern, particularly in developing countries. The first cholera outbreak in Zambia was documented in the 1970s, with recurring epidemics reported since then. In 2023, a cholera outbreak affected Zambia, particularly in districts bordering Malawi, Mozambique and the Democratic Republic of Congo, with significant cases reported in these neighbouring countries. This study aims to analyse cholera cases and isolates obtained during the 2023 epidemic, focusing on geographical distribution, genetic relatedness of isolates and their antibiotic resistance profiles. Methods. Stool samples were collected from patients presenting with cholera-like symptoms across three provinces of Zambia. A total of 98 samples were cultured on thiosulphate citrate bile salts sucrose agar, resulting in 32 sequenced V. cholerae isolates. Whole-genome sequencing was performed using Oxford Nanopore Technology, and phylogenetic inference was also achieved by the analysis of SNPs. Phenotypic antimicrobial resistance testing was conducted following Clinical and Laboratory Standards Institute guidelines. The genomic data were analysed for virulence factors and antimicrobial resistance profiles. Results. Of the 98 stool samples tested, 38 confirmed cholera cases were identified. A subset of 32 confirmed V. cholerae isolates, predominantly from the Eastern Province of Zambia ( n =21), was selected for whole-genome sequencing. Genomic analysis revealed that all isolates belonged to the seventh pandemic El Tor lineage and the O1 serogroup, with two distinct clades identified corresponding to the 10th (T10) and 15th (T15) transmission events. Geographical analysis indicated a predominance of Ogawa serotypes in Eastern Province and Inaba in Northern Province. The virulence gene analysis confirmed the presence of key cholera toxin genes ( ctxA and ctxB ) and intestinal colonization factors. All isolates carried genes or mutations predicted to confer resistance to multiple antibiotics, including decreased susceptibility to ciprofloxacin, recommended for the treatment of cholera by the World Health Organization. Conclusion. The findings highlight the critical need for enhanced surveillance and targeted interventions to mitigate cholera outbreaks in Zambia. The emergence of resistant V. cholerae strains necessitates innovative strategies, including improved water sanitation, vaccination efforts and novel therapeutic approaches to combat this enduring public health threat.

9 April 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
NKNawa Kalima
Nawa Kalima
TITadatsugu Imamura
Tadatsugu Imamura
ICIlunga Chambah
Ilunga Chambah
NMNyuma Mbewe
Nyuma Mbewe
ASAnnel Sinkala
Annel Sinkala
LMLloyd Mulenga
Lloyd Mulenga
Background: Zambia declared a cholera outbreak on 18 October 2023 and, as of 31 June 2024, had recorded 23 381 cases and 740 deaths. Of the patients seen at the 2 main cholera treatment centers in the capital Lusaka, a third of them were children aged 0 to 15 years. Despite the significant pediatric cholera burden, risk factors for mortality and prolonged hospitalization remain unknown. Methods: A retrospective data review was conducted by examining the clinical characteristics of patients aged 0 to 15 years hospitalized at the 2 cholera treatment centers between 15 October 2023 and 31 March 2024. Descriptive analysis was conducted for patient characteristics, and penalized logistic regression (PLR) was used to analyze risk factors for the outcomes. Results: A total of 1891 patients were identified, among which 1.4% (18/1253) had fatal outcomes and 47.9% (399/833) had hospitalization >2 days. By the PLR, the following factors were independently correlated with hospitalization >2 days: HIV infection (odds ratio [OR], 6.89; 95% CI, 1.32–71.9), severe acute malnutrition (SAM; OR, 10.8; 95% CI, 2.91–61.1), and dehydration treatment plans B (OR, 3.93; 95% CI, 1.80–9.27) and C (OR, 7.54; 95% CI, 2.71–22.9). For the fatal outcome, none of them independently showed any significant correlations by the PLR, although younger age and SAM were positively associated by bivariate analysis. Conclusions: Comorbidities such as SAM and HIV, being on plan B or C, and deteriorating and requiring more intense treatment are associated with longer hospitalization. Risk factors for mortality need to be further investigated.